Governance

What questions should a CIO ask before buying healthcare AI?

Before buying healthcare AI, a CIO should examine patient-data location and access, human review and audit trails, HIS/EMR integration, data-residency and compliance terms, whether the product is a point tool or governed platform, and how the institution can retrieve its data on exit.

Put the evidence in context

Review the intended task, source information, human checkpoints and observed results together. A benchmark or sandbox result has a defined scope; it does not establish suitability, approval or performance for every institution.

Read the full explanation
Discuss this step for your team

The failure mode in healthcare AI procurement is buying a demo, not an operating model. A slick single-task tool can still leave the CIO owning integration debt, an unclear audit story, and patient data copied somewhere they cannot see. The questions above shift evaluation from 'what can it do' to 'how is it governed, integrated, and accountable'.

Insist on least-privilege access, action-level audit evidence, and an appropriate human checkpoint before AI output enters an institutional record. Confirm that any export, integration, or writeback path is verified for the target system. Micromeet Care Workspace connects Patient Access & Appointments, MCU / Diagnostics, Clinical Reporting & Delivery, and Care Loop on a governed foundation; Lifelong Patient Context spans the domains, while AI Scribe is a shared capability. Claim Readiness is discussed separately as a payer-workflow perspective and content theme, not as a Care Workspace product or module. It begins with purpose-limited, institution-approved patient context and clinician-reviewed documentation; authorized institutional staff own coding and submission, while the payer system owns adjudication. The CIO is buying an accountable operating model, not just a model.

Related questions

Is data residency really a buying criterion?+
Yes. Data location is one factor in deciding which laws and transfer requirements apply, alongside the parties, data subjects, processing purposes, and deployment model. A CIO should obtain residency, encryption, transfer, and retention terms in writing before signing.
How do I tell a point tool from a platform in a sales demo?+
Ask what happens when you add a second and third use case. A point tool often adds another integration or governance surface unless shared controls already exist; a platform can reuse approved context, access controls, and audit mechanisms. The answer reveals your integration and governance cost over time.